Ebola is in America – and, finally, within range of Big Pharma

14th October 2014

Research into tropical diseases is chronically neglected, but the horror of this epidemic could transform the battle against them.

As the Ebola epidemic continues to rage in west Africa, with more than 3,000 dead and infections doubling every few weeks, the first confirmed case in the US last week stepped up global fears over the rapid spread of the incurable virus.

But behind the gruesome headlines, the scale of the outbreak has been raising hopes that it could focus minds at the world’s biggest pharmaceutical groups, boosting research on other devastating tropical diseases that have been neglected for years by the drugs makers.

Read more at source article www.theguardian.com

Leave a Reply

Your email address will not be published.

38 − 34 =

« back to posts